Monday, Dec 18, 2017
engineered enzymes for better healthcare

Science-b

Enzolve Technologies research laboratories and office space are based at the Belfield Innovation Park, in the grounds of the University College Dublin. The Company and its R&D facilities are accredited to ISO 13485/2003 quality system to comply with the European IVD directives.

Research_and_Development

 

 

 

Enzolve Technologies also has access to state of the art equipment and facilities in the Conway Institute and, through the Company’s Innovation Partnership project supported by Enterprise Ireland, has direct input from UCD scientists.

 

Language Selection

Search

Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…

Read more...

Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…

Read more...

UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…

Read more...